Physician profile
Ewa Blachowicz
NPI 1861514408
$7,133.76
in general payments reported to CMS, 2019-2025
34 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $609 · 2022: $2,741 · 2023: $2,137 · 2024: $1,112 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,291 · Travel and Lodging: $315 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,290.65 |
| Travel and Lodging | $314.71 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,396.65 | 2022-2025 | Interstim |
| Teleflex LLC | $1,074.31 | 2021-2024 | Urolift |
| Axonics, INC. | $734.98 | 2022-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $622.14 | 2023-2024 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $344.65 | 2021-2024 | Myrbetriq, Xtandi |
| Urovant Sciences INC | $308.74 | 2021-2022 | |
| Janssen Biotech, INC. | $251.37 | 2022-2024 | Erleada |
| Telix Pharmaceuticals | $245.35 | 2023 | Illuccix |
| Olympus America INC. | $180.04 | 2021-2025 | Itind System |
| Antares Pharma, INC. | $166.94 | 2021-2024 | Xyosted |
| Abbvie INC. | $152.44 | 2022-2023 | |
| Tolmar, INC. | $150.13 | 2023-2025 | Jatenzo |
| Convatec INC. | $149.53 | 2022-2024 | |
| Coloplast Corp | $142.99 | 2023-2024 | Speedicath |
| Procept Biorobotics Corporation | $142.35 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $141.54 | 2024 | Xiaflex |
| 180 Medical, INC. | $135.03 | 2021-2024 | |
| Boston Scientific Corporation | $127.11 | 2022-2025 | Axonics |
| Endo Pharmaceuticals INC. | $112.02 | 2023 | Xiaflex |
| Allergan, INC. | $88.80 | 2021 | |
| Progenics Pharmaceuticals, INC. | $85.58 | 2025 | |
| Dendreon Pharmaceuticals LLC | $74.20 | 2024-2025 | Provenge |
| Myovant Sciences INC. | $44.87 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $38.94 | 2024 | Trelstar |
| Accord Healthcare, INC. | $35.42 | 2024 | |
| Rochester Medical Corporation | $28.67 | 2021 | |
| Clarus Therapeutics INC. | $25.25 | 2021 | |
| Genzyme Corporation | $24.17 | 2022 | |
| Glaxosmithkline, LLC. | $21.82 | 2023 | Shingrix, Arexvy |
| Cardinal Health 414 LLC | $21.27 | 2023 | |
| Blue Earth Diagnostics | $19.99 | 2022 | |
| Alnylam Pharmaceuticals INC. | $15.75 | 2022 | |
| Urogen Pharma, INC. | $15.75 | 2023 | Jelmyto |
| Halozyme INC | $14.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ewa Blachowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.